Vol2 Paper 10

posted Aug 14, 2018, 12:58 AM by Yaseen Raouf Mohammed   [ updated Sep 4, 2018, 1:20 AM ]

 Ehssan Nissiaf Jasim Al-Obaidy

 Department of Physiology, pharmacology and Biochemistry College of Veterinary Medicine- Diyala University/Iraq

 Muna, M.Ismail

 Department of Physiology, pharmacology and Biochemistry College of Veterinary Medicine- Diyala University/Iraq

 Nadia Ahmed Salih Al-Guburi

 Department of Chemistry College of Education –Tikrit University /Iraq

Vitamin B12, B6 being water-soluble is excreted in the urine when administered in excess. Lipid profile and Homocystien is important relation with heart disease. High levels of the amino acid homocysteine in the blood are associated with heart disease increased intake of vitamin B12 has been found to decrease homocysteine levels, Aim: The present study was undertaken to investigate the effects of dietary excess of vitamin B6 and B12 total lipid and the Homocystein. Materials and Methods: A total of 48 rabbits were included in the study. Control groups (CG-10, n = 8 for 10 days; CG-15, n = 8 for 15 days; CG-20, n = 8 for 20 days). The experimental groups (EG-10, n = 8; EG-15, n = 8; EG-20, n = 8) received 5 mg/ kg vitamin B6, B12 daily for 10 days, 15 days and 20 days .HDL,Cholesterol and total lipid levels and Homocystiene were measured and compared in CGs and EGs. Results: The total serum cholesterol levels were significantly lower (P < 0.05) although serum HDL levels were significantly higher (P < 0.01) in all EGs. Total serum lipid levels were higher in EG-15 and EG-20 groups than in CGs. a relationship between serum total lipid and HDL levels in theEG-15 and EG-20 groups is suggested. Conclusions: Dietary excess of vitamin B6, B12 intake reduces serum total cholesterol levels, but not serum HDL and total lipid levels, and also causes decrease in homocystine levels as treatment.

Vitamin B12, B6, Cholesterol, Lipid profile, Homocystiene.


[1] C.A.Burtis and E.Ashwood.Tietz fundamentals of clinical biochemistry. Saunders, Elsevier: Missouri 2008. p. 488–9.
[2] V. Herbert. Vitamin B-12. In: Nutrition reviews; Present Knowledge in Nutrition. The Nutrition Foundation Inc, Washington DC, [1984] pp 347-64.
[3] V. Herbert. The 1986 Herman Award lecture. Nutrition science as a continually unfolding story: the folate and vitamin B-12 paradigma. Am J Clin Nutr 1987, 46: 387- 402.101
[4] V. Herbert and K.C Das. Folic acid and vitamin B12 .In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. 8th ed. Philadelphia: Lea and Febiger; 1994,402–425.
[5] S.K.Lam. Advanced Nutrition: Macronutrients, Micronutrients, and Metabolism. CRC Press,
Taylor & Francis Group. 2009. pp34-50.
[6] Z.G.Abbas and A.B Swai. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr Med J 1997; 74: 803–807.
[7] N.S Lee, G .Muhs and H.Fisher.Dietary pyridoxine interaction with tryptophan or histidine on brain serotonin and histamine metabolism. Pharmacol Biochem Behav1988; 29: 559-564.
[8] V .R. Avichandran and R. Selvam. Increased lipid peroxidation in kidney of vitamin B6-deficient rats. Biochem Int 1990; 21: 599–605.
[9] R. Selvam and V. Ravichandran. Increased lipid peroxidation in kidney of vitamin B6-deficient rats. Biochem Int 1991; 23: 1007-1017.
[10] J.R. Kanofsky and P.Sima. Singlet oxygen production from the reactions of ozone with biological molecules. J Biol Chem 1991; 266: 9039-9042
[11] A.N John .Biochemical, Physiological, Molecular Aspects of Human Nutrition Saunders, Elsevier Inc. [2006].
[12] J.L.Loew.Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline.Washington, DC: National Academy Press,1998.
[13] N.A.Al-Guburi and E.N.Al-Obaidy. Study Plasma Homocysteine Level in Alzheimer’s Disease Andits Relationship with the Folic Acid and Vitamin B12 in Alshamaiah Baghdad Hospital
.International Journal of Science and Research [IJSR]. [March 2013]: 614-620.
[14] G. Anker and P.M Ueland. Plasma levels of atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen. Int J Cancer1995;60:365–8.
[15] J.M .Alinowska and J.Kolodziejczyk.The disturbance of hemostasis induced by hyperhomocysteinemia; the role of antioxidants.2015.Vol. 59, No 2/2012185–194.
[16] A.M.Troen , E.Lutgens and D.E.Smith.The atherogenic effect of excess methionine intake PNAS December 9, 2003 vol. 100 no. 25 15089–15094
[17] S. R. Ravichandran. Lipid peroxidation in liver of vitamin B6 deficient rats. J Nutr Biochem 1991; 2: 245–250.
[18] J.S.Lim. Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and [Na++K+]-ATPase activity reduction in high glucose- treated human erythrocytes. Free Radic Biol Med 2001; 30: 232–237.
[19] V.Kucukatay.A.A.Yargicoglu.Changes in somatosensorial evoked potentials, lipid peroxidation and antioxidant enzymes in experimental diabetes: effect of sulfur dioxide. Arch Environ
Health 2003; 58: 14-22.
[20] M.C.Schaeffer , D.Gretz and D.W.Gietzen. Dietary excess of vitamin B-6 affects the concentrations of amino acids in the caudate nucleus and serum and the binding properties of 102
serotonin receptors in the brain cortex of rats. J Nutr 1998; 128: 1829-1835.
[21] A.Sermet. M.Atmaca and H. Diken. The effect of pyridoxine supplementation on plasma lipoproteins and its relationship with atherogenic risk. Biomedical Letter 1999; 59: 7-14.
[22] W.K.Helzlsouer and K.J.Comstock .A prospective study on folate, B12, and pyridoxal 5’- phosphate [B6] and breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:209–17.
[23] J.Chen and E.Giovannucci. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996;56:4862–4.
[24] C.B.Delorme and P.J.Lupien. The effect of a long-term excess of pyridoxine on the fatty acid composition of the major phospholipids in the rat. J Nutri 1976; 106: 976-984.
[25] C.M.Hinse and P.J Lupien. Cholesterol metabolism and vitamin B6. 3. The stimulation of hepatic cholesterogenesis in the vitamin B6- deficient rat. Can J Biochem 1981; 49: 933-935.
[26] L.F Major and P.F Goyer. Effects of disulfiram and pyridoxine on serum cholesterol. Ann Intern Med 2000; 11: 93-96.
[27] S. Ziakka and G .Rammos. The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis. Int Urol Nephrol 2001; 33: 559-562
[28] T. Inubushi and T .Takasawa. Changes of glucose metabolism and skin-collagen neogenesis in vitamin B6 deficiency. Biofactors 2005; 23: 59-67.
[29] A .Wasilewska and M. Narkiewicz. Is there any relationship between lipids and vitamin B levels in persons with elevated risk of atherosclerosis.Med Sci Monit2003; 9: 147-151.
[30] C .Loschiavo and S .Ferrari. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure. Clin Nephrol 1990; 34: 267-271.
[31] W.Y.Ong , B. Tan and N.Pan. Increased iron staining in the cerebral cortex of cholesterol fed rabbits. Mech Ageing Dev 2004; 125[4]: 305-313.
[32] R. Harripersad and F.J. Burger. The effect of a subnormal dose of vitamin B6 on plasma lipid in the rat. Int J Vitam Nutr Res 1997; 67: 95-101.
[33] D.M. Morre and A.Z.Wasynczuk. Neuronal development in vitamin B6 deficiency. Ann N Y Acad Sci 1990; 585: 202-218.[34] R. Demir, G .Acar, G .Tanriover. Effects of excess vitamin B6 intake on cerebral cortexneurons in rat: an ultrastructural study. Folia Histochem Cytobiol 2005; 43:143-

View All Artical